Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “DENALI THERAPEUTICS INC.”

41 pharma patents match "DENALI THERAPEUTICS INC." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 41
Index total 30,257
Page 2 / 2

Quick answer

This filtered view shows 41 pharmaceutical patents matching "DENALI THERAPEUTICS INC." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

41 results for “DENALI THERAPEUTICS INC.” · 30,257 patents in full index Clear search

  1. US 11214565

    Compound, compositions, and methods

    DENALI THERAPEUTICS INC. · Granted Jan 4, 2022 · Expires Dec 30, 2041

    granted
  2. US 11203600

    Kinase inhibitors and uses thereof

    DENALI THERAPEUTICS INC. · Granted Dec 21, 2021 · Expires Dec 16, 2041

    granted
  3. US 11174262

    Compounds, compositions and methods

    DENALI THERAPEUTICS INC. · Granted Nov 16, 2021 · Expires Nov 11, 2041

    granted
  4. US 11124567

    Anti-TREM2 antibodies and methods of use thereof

    DENALI THERAPEUTICS INC. · Granted Sep 21, 2021 · Expires Sep 16, 2041

    granted
  5. US 11111235

    Compounds, compositions, and methods

    DENALI THERAPEUTICS INC. · Granted Sep 7, 2021 · Expires Sep 2, 2041

    granted
  6. US 11072618

    Compounds, compositions and methods

    DENALI THERAPEUTICS INC. · Granted Jul 27, 2021 · Expires Jul 22, 2041

    granted
  7. US 10870837

    Fusion proteins comprising enzyme replacement therapy enzymes

    DENALI THERAPEUTICS INC. · Granted Dec 22, 2020 · Expires Dec 17, 2040

    granted
  8. US 10851088

    Polymorphs and solid forms of a pyrimidinylamino-pyrazole compound, and methods of production

    DENALI THERAPEUTICS INC. · Granted Dec 1, 2020 · Expires Nov 26, 2040

    granted
  9. US 10709692

    Isoxazolidine derived inhibitors of receptor interacting protein kinase 1 (RIPK1)

    DENALI THERAPEUTICS INC. · Granted Jul 14, 2020 · Expires Jul 9, 2040

    granted
  10. US 10604535

    Compounds, compositions and methods

    DENALI THERAPEUTICS INC. · Granted Mar 31, 2020 · Expires Mar 26, 2040

    granted
  11. US 10590114

    Compounds, compositions, and methods

    DENALI THERAPEUTICS INC. · Granted Mar 17, 2020 · Expires Mar 12, 2040

    granted
  12. US 10370361

    Polymorphs and solid forms of a pyrimidinylamino-pyrazole compound, and methods of production

    DENALI THERAPEUTICS INC. · Granted Aug 6, 2019 · Expires Aug 1, 2039

    granted
  13. US 10131676

    Compounds, compositions and methods

    DENALI THERAPEUTICS INC. · Granted Nov 20, 2018 · Expires Nov 15, 2038

    granted
  14. US 9932325

    Compounds, compositions, and methods

    DENALI THERAPEUTICS INC. · Granted Apr 3, 2018 · Expires Mar 29, 2038

    granted
  15. US 9896458

    Compounds, compositions and methods

    DENALI THERAPEUTICS INC. · Granted Feb 20, 2018 · Expires Feb 15, 2038

    granted
  16. US 9815850

    Compounds, compositions and methods

    DENALI THERAPEUTICS INC. · Granted Nov 14, 2017 · Expires Nov 9, 2037

    granted
  17. US 9802927

    Oxadiazine compounds and methods of use thereof

    DENALI THERAPEUTICS INC. · Granted Oct 31, 2017 · Expires Oct 26, 2037

    granted